Low serum testosterone levels independently associated with fall risk in elderly men

Prolonged hypogonadism may result in erectile dysfunction, decreased libido, anemia, sarcopenia, memory loss, bone mineral loss, and the metabolic syndrome.

While a low serum testosterone level is well-known for its association with osteoporosis, the impact of hypogonadism on overall physical functioning and fall risk has not been prospectively evaluated.

In the October 23 issue of the Archives of Internal Medicine, Orwoll and colleagues from the Osteoporotic Fractures in Men Study Group report on a longitudinal, observational study designed to evaluate the relationship between serum testosterone and the development of age-related disorders, including the risk of falling.

A total of 2586 men ages 65 to 99 were randomly selected from a cohort of 5995 volunteers. Serum testosterone and estradiol levels were measured at baseline and compared to the incidence of falls, which were ascertained every 4 months for 4 years.

Fifty six percent of men reported at least one fall over the follow-up period. The risk of a fall was 40% higher in men in the lowest testosterone quartile when compared to those in the highest testosterone quartile. Interestingly, the association between low serum testosterone and falling was highest among the youngest men (relative risk 1.8, 95% CI 1.2 to 2.7) and was not statistically significant in those men over 80 years of age. This association persisted despite adjusting for overall physical performance.

This important study suggests that in a cohort of men older than 65 years, a low serum testosterone was associated with an increased risk of falling which was independent of the patient's overall physical performance. While testosterone replacement in this age group should be used cautiously due to their higher prostate cancer risk, these data certainly should heighten our awareness that androgen deprivation is not innocuous and may be associated with significant risks beyond bone mineral loss.

Eric Orwoll, MD; Lori C. Lambert, MS; Lynn M. Marshall, ScD; Janet Blank, MS; Elizabeth Barrett-Connor, MD; Jane Cauley, MD; Kris Ensrud, MD; Steven R. Cummings, MD; for the Osteoporotic Fractures in Men Study Group

Arch Intern Med. 2006;166:2124-2131.

By Ricardo Sanchez-Ortiz

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers develop stable compound for targeted alpha therapy in prostate cancer